Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes

被引:36
作者
Ahn, Yong-Tae [1 ]
Huang, Boli [1 ]
McPherson, Lisa [1 ]
Clayberger, Carol [1 ]
Krensky, Alan M. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Div Immunol & Transplantat Biol, Stanford, CA 94305 USA
关键词
D O I
10.1128/MCB.01071-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chemokine RANTES (regulated upon activation normal T cell expressed and secreted) is expressed "late" (3 to 5 days) after activation in T lymphocytes. In order to understand the molecular events that accompany changes in gene expression, a detailed analysis of the interplay between transcriptional machinery and chromatin on the RANTES promoter over time was undertaken. Kruppel-like factor 13 (KLF13), a sequence-specific DNA binding transcription factor, orchestrates the induction of RANTES expression in T lymphocytes by ordered recruitment of effector molecules, including Nemo-like kinase, p300/cyclic AMP response element binding protein (CBP), p300/CBP-associated factor, and Brahma-related gene 1, that initiate sequential changes in phosphorylation and acetylation of histones and ATP-dependent chromatin remodeling near the TATA box of the RANTES promoter. These events recruit RNA polymerase II to the RANTES promoter and are responsible for late expression of RANTES in T lymphocytes. Therefore, KLF13 is a key regulator of late RANTES expression in T lymphocytes.
引用
收藏
页码:253 / 266
页数:14
相关论文
共 61 条
[1]   Deciphering the transcriptional histone acetylation code for a human gene [J].
Agalioti, T ;
Chen, GY ;
Thanos, D .
CELL, 2002, 111 (03) :381-392
[2]   FKLF-2: a novel Kruppel-like transcriptional factor that activates globin and other erythroid lineage genes [J].
Asano, H ;
Li, XS ;
Stamatoyannopoulos, G .
BLOOD, 2000, 95 (11) :3578-3584
[3]   The chromatin remodelling factor Brg-1 interacts with β-catenin to promote target gene activation [J].
Barker, N ;
Hurlstone, A ;
Musisi, H ;
Miles, A ;
Bienz, M ;
Clevers, H .
EMBO JOURNAL, 2001, 20 (17) :4935-4943
[4]   Histone modifications in transcriptional regulation [J].
Berger, SL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (02) :142-148
[5]   Targeting promiscuous signaling pathways in cancer:: another Notch in the bedpost [J].
Beverly, LJ ;
Capobianco, AJ .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (12) :591-598
[6]   Structures of protein domains that create or recognize histone modifications [J].
Bottomley, MJ .
EMBO REPORTS, 2004, 5 (05) :464-469
[7]  
Chan HM, 2001, J CELL SCI, V114, P2363
[8]   MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation [J].
Clayton, AL ;
Mahadevan, LC .
FEBS LETTERS, 2003, 546 (01) :51-58
[9]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[10]   CONTINGENT GENETIC REGULATORY EVENTS IN LYMPHOCYTE-T ACTIVATION [J].
CRABTREE, GR .
SCIENCE, 1989, 243 (4889) :355-361